Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy.

Abstract:

:Prostaglandins have been shown to relax the smooth muscle of the ductus arteriosus in the fetus in utero. This physiologic action has been applied to the management of newborn infants with certain types of congenital malformations. Infants with lesions producing right ventricular outflow obstruction have a compromised pulmonary circulation and require a patent ductus arteriosus for adequate pulmonary blood flow. Infusion of alprostadil (PGE1) dilates the ductus, increases pulmonary blood flow, and thereby improves oxygenation. Likewise, infants with aortic arch interruption or coarctation of the aorta are dependent on an open ductus to maintain lower body perfusion. Alprostadil is of great benefit in this situation as well. The side effects of alprostadil include peripheral vasodilation and hypotension and, most importantly, apnea. Hyperpyrexia and jitteriness may also occur. Side effects occur only in about 20% of infants and usually are easily reversed. The benefits therefore greatly outweigh the risks, but careful monitoring is essential.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Heymann MA,Clyman RI

doi

10.1002/j.1875-9114.1982.tb04522.x

subject

Has Abstract

pub_date

1982-05-01 00:00:00

pages

148-55

issue

3

eissn

0277-0008

issn

1875-9114

journal_volume

2

pub_type

杂志文章,评审
  • Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents.

    abstract::Endothelin (ET)-1 is an endothelium-derived peptide with potent vasoconstrictor and proliferative properties. The ET system is activated in several cardiovascular disease states associated with functional and structural vascular changes, including hypertension and heart failure. The two ET receptor subtypes are known ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.22.1.54.33505

    authors: Ergul A

    更新日期:2002-01-01 00:00:00

  • Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group.

    abstract::Concerns about cross-allergenicity between sulfonamide antibiotics and nonantibiotic, sulfonamide-containing drugs persist and can complicate patients' drug therapy unnecessarily. No interaction between the human immune system and the sulfonamide functional group has been demonstrated. The immunologic determinant of t...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.24.9.856.36106

    authors: Brackett CC,Singh H,Block JH

    更新日期:2004-07-01 00:00:00

  • Difficulties in anticoagulation management during coadministration of warfarin and rifampin.

    abstract::The clinical significance of rifampin's induction of warfarin metabolism is well documented, but no published studies or case reports have quantified this interaction with respect to the international normalized ratio (INR). A patient receiving concomitant rifampin and warfarin to treat a mycobacterial infection and i...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.21.15.1240.33897

    authors: Lee CR,Thrasher KA

    更新日期:2001-10-01 00:00:00

  • Introduction to immunology.

    abstract::The immune system is a complex network of components functioning to provide host defense. This network consists of immunologic cells and their products (e.g., interleukins and colony-stimulating factors), organs, tissues, complement, and major histocompatibility complex antigens. These components are organized into sp...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: McIntyre WJ,Tami JA

    更新日期:1992-01-01 00:00:00

  • Effects of esomeprazole on the pharmacokinetics of atazanavir and fosamprenavir in a patient with human immunodeficiency virus infection.

    abstract::The effects of proton pump inhibitors on the pharmacokinetics of atazanavir and amprenavir (administered as fosamprenavir) were rigorously evaluated in healthy volunteers in two studies, but formal studies in persons infected with human immunodeficiency virus (HIV) are lacking. We describe a 65-year-old man with HIV w...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.26.4.511

    authors: Kiser JJ,Lichtenstein KA,Anderson PL,Fletcher CV

    更新日期:2006-04-01 00:00:00

  • Renal function and methotrexate clearance in children with newly diagnosed leukemia.

    abstract:STUDY OBJECTIVES:To determine whether glomerular filtration rate (GFR) changes during induction chemotherapy in children with leukemia, and to examine GFR as a determinant of pharmacokinetic variability of methotrexate clearance. DESIGN:Prospective, unblinded observational study in consecutive patients. SETTING:A res...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Murry DJ,Synold TW,Pui CH,Rodman JH

    更新日期:1995-03-01 00:00:00

  • Transitioning from traditional to novel anticoagulants: the impact of oral direct thrombin inhibitors on anticoagulation management.

    abstract::Limitations of traditional anticoagulants have led to the need for structured services to provide anticoagulation monitoring. Anticoagulation management services have historically filled this role. Novel antithrombotic agents currently in development have the potential to improve on the limitations of vitamin K antago...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.15.199s.43159

    authors: Nutescu EA,Spinler SA,Dager WE,Bussey HI

    更新日期:2004-10-01 00:00:00

  • Effects of antiepileptic drug substitutions on epileptic events requiring acute care.

    abstract:STUDY OBJECTIVES:To determine the odds of antiepileptic drug substitution among patients who had an epileptic event requiring acute care-ambulance service, emergency department visit, or hospitalization-relative to patients who did not have an event, and to compare these results with those from a recent study involving...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.29.7.769

    authors: Rascati KL,Richards KM,Johnsrud MT,Mann TA

    更新日期:2009-07-01 00:00:00

  • Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus.

    abstract:STUDY OBJECTIVE:To determine the effects of low-dose pioglitazone on plasma adipocyte-derived cytokines, high-sensitivity C-reactive protein (hs-CRP), and components of the metabolic syndrome in adults with the metabolic syndrome without diabetes mellitus. DESIGN:Prospective, randomized, double-blind, placebo-controll...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/phar.1713

    authors: Vu A,Kosmiski LA,Beitelshees AL,Prigeon R,Sidhom MS,Bredbeck B,Predhomme J,Deininger KM,Aquilante CL

    更新日期:2016-03-01 00:00:00

  • Identifying Subsequent Therapies in Patients with Advanced Non-Small Cell Lung Cancer and Factors Associated with Overall Survival.

    abstract:STUDY OBJECTIVES:To identify subsequent therapies used after first-line therapies in patients with advanced non-small cell lung cancer (NSCLC), compare overall survival (OS) associated with subsequent therapies, and evaluate factors associated with OS in these patients. METHODS:The study was a retrospective cohort ana...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1826

    authors: Afanasjeva J,Hui RL,Spence MM,Chang J,Schottinger JE,Millares M,Rashid N

    更新日期:2016-10-01 00:00:00

  • CYP2D6, N-acetylation, and xanthine oxidase activity in cystic fibrosis.

    abstract:STUDY OBJECTIVE:To determine the activity of CYP2D6, N-acetylation, and xanthine oxidase, three drug-metabolizing enzyme systems, in patients with cystic fibrosis and compare the findings with those in individuals without the disease. DESIGN:Prospective cohort study. SETTING:General pediatrics service. PATIENTS:Fift...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Bosso JA,Liu Q,Evans WE,Relling MV

    更新日期:1996-09-01 00:00:00

  • Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice.

    abstract::Antiretroviral (ART) therapy for the treatment of human immunodeficiency virus (HIV) infection has undergone significant changes over the past 30 years. Many single-tablet regimens (STRs), including newer fixed-dose combination (FDC) tablets, are available, offering patients several options for choosing a treatment re...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2055

    authors: McCoy C,Badowski M,Sherman E,Crutchley R,Smith E,Chastain DB,Society of Infectious Diseases Pharmacists.

    更新日期:2018-01-01 00:00:00

  • Immune-mediated coagulopathy: a case report.

    abstract::Surgical hemostasis may be achieved by using a number of physical, chemical, or biologic methods. One such method is with topical thrombin; however, one member of that class of drugs, bovine-derived thrombin, is associated with potentially serious consequences such as development of immune-mediated coagulopathy. This ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.29.pt2.13S

    authors: Naoum JJ

    更新日期:2009-07-01 00:00:00

  • Resolution of tumor pain with EMLA cream.

    abstract::A 69-year-old woman was admitted for control of intractable rectal pain caused by a 4-cm malignant mass. She was treated successfully with EMLA (eutectic mixture of local anesthetics) cream applied every 8 hours and covered with a Xeroform dressing. Despite an increase in tumor size to 6 cm, her pain control was maint...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Stegman MB,Stoukides CA

    更新日期:1996-07-01 00:00:00

  • Review of Real-World Implementation Data on Emtricitabine-Tenofovir Disoproxil Fumarate as HIV Pre-exposure Prophylaxis in the United States.

    abstract::The antiretroviral combination of emtricitabine-tenofovir disoproxil fumarate (FTC/TDF) was approved by the U.S. Food and Drug Administration for use as pre-exposure prophylaxis (PrEP) in individuals at high risk for acquiring human immunodeficiency virus (HIV) in July 2012. Since then, Centers for Disease Control and...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2240

    authors: Adams JL,Shelley K,Nicol MR

    更新日期:2019-04-01 00:00:00

  • The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients.

    abstract:STUDY OBJECTIVE:To evaluate the safety, tolerability, and pharmacokinetic profile of fosphenytoin, a water-soluble phenytoin prodrug, after intramuscular and intravenous administration. DESIGN:Open-label study of intramuscular administration, and double-blind, randomized study of intravenous administration. SETTING:S...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Boucher BA,Feler CA,Dean JC,Michie DD,Tipton BK,Smith KR Jr,Kramer RE,Young B,Parks BR Jr,Kugler AR

    更新日期:1996-07-01 00:00:00

  • Impact of an institution-specific hospital-acquired pneumonia protocol on the appropriateness of antibiotic therapy and patient outcomes.

    abstract:STUDY OBJECTIVE:To evaluate the impact of a hospital-acquired pneumonia (HAP) protocol on appropriateness of empiric antibiotic therapy, antibiotic deescalation, antibiotic duration, patient mortality, and length of stay. DESIGN:Before- and after-study of protocol implementation. SETTING:A 450-bed, academic medical c...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.7.852

    authors: Lancaster JW,Lawrence KR,Fong JJ,Doron SI,Garpestad E,Nasraway SA,Devlin JW

    更新日期:2008-07-01 00:00:00

  • Telavancin: an antimicrobial with a multifunctional mechanism of action for the treatment of serious gram-positive infections.

    abstract::Telavancin is a once-daily lipoglycopeptide antibiotic structurally derived from vancomycin. It has broad-spectrum activity against gram-positive bacteria, including strains with reduced susceptibility to vancomycin. Telavancin's multifunctional mechanism of action, including inhibition of peptidoglycan synthesis and ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.28.4.458

    authors: Leonard SN,Rybak MJ

    更新日期:2008-04-01 00:00:00

  • Treatment of supraventricular tachyarrhythmias with intravenous calcium channel blockers: are subtle differences worth the cost?

    abstract::Verapamil and diltiazem are effective in terminating paroxysmal supraventricular tachycardias and slowing ventricular response during atrial fibrillation or flutter. Results from clinical trials for each individual drug demonstrate comparative efficacy rates, and both drugs share the same contraindications and relativ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Cheiman DM,Shea BF,Kelly RA

    更新日期:1996-09-01 00:00:00

  • The effect of low-dose phenytoin on high-density lipoprotein cholesterol.

    abstract::We examined whether low doses of phenytoin, which should be associated with few dose-related side effects, may increase the levels of high-density lipoprotein (HDL) cholesterol. Of 35 healthy adult men who consented to participate, 31 completed the study. They took no medications and consumed no alcohol during the stu...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: McKenney JM,Petrizzi KS,Briggs GC,Wright JT Jr

    更新日期:1992-01-01 00:00:00

  • White Paper on Natural Products.

    abstract::The American College of Clinical Pharmacy (ACCP) published an initial white paper on herbal products in 2000. Since then, the global market for natural products has continued to expand, with tens of millions of consumers using such products on an annual basis in the United States alone. However, despite this expansion...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1874

    authors: Gabay M,Smith JA,Chavez ML,Goldwire M,Walker S,Coon SA,Gosser R,Hume AL,Musselman M,Phillips J,Abe AM

    更新日期:2017-01-01 00:00:00

  • Impact of High-Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant Recipients.

    abstract:STUDY OBJECTIVE:To evaluate the clinical course and long-term impact of high-dose acyclovir (HD-A, 800 mg 4 times/day) cytomegalovirus (CMV) prophylaxis failure in a CMV-seropositive abdominal solid organ transplant population. DESIGN:Retrospective cohort study. SETTING:Tertiary academic medical center. PATIENTS:A t...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2126

    authors: Siodlak M,Jorgenson MR,Descourouez JL,Leverson GE,Mandelbrot DA,Smith JA,Redfield RR

    更新日期:2018-07-01 00:00:00

  • Pharmacologic and pharmacokinetic comparison of antianginal agents.

    abstract::Calcium channel blockers, nitrates, and beta blockers are the primary agents used for the treatment of angina. Calcium has a central role in excitation-contraction, action potential generation, and ischemic cell death. The three currently available calcium antagonists are nifedipine, verapamil, and diltiazem. Second-g...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1987.tb04052.x

    authors: Angaran D

    更新日期:1987-01-01 00:00:00

  • Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain.

    abstract::Ziconotide intrathecal infusion was recently approved by the United States Food and Drug Administration for the treatment of intractable severe chronic pain. Patients with neuropathic pain make up a significant population among those who experience chronic pain for which there are less than optimal pharmacotherapeutic...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.26.3.395

    authors: Wermeling DP,Berger JR

    更新日期:2006-03-01 00:00:00

  • Clinical practice guidelines in nephrology: evaluation, classification, and stratification of chronic kidney disease.

    abstract::The National Kidney Foundation developed and oversees the Kidney Disease Outcomes Quality Initiative, a process that develops clinical practice guidelines in nephrology. Recent guidelines address the evaluation, classification, and stratification of chronic kidney disease (CKD). These guidelines provide, for the first...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.25.4.491.61034

    authors: Bailie GR,Uhlig K,Levey AS

    更新日期:2005-04-01 00:00:00

  • Evaluation of the Effectiveness of Two Morphine Protocols to Treat Neonatal Abstinence Syndrome in a Level II Nursery in a Community Hospital.

    abstract::The authors sought to evaluate the impact on length of hospital stay and treatment duration of morphine after implementation of a change in the institutional protocol for managing neonatal abstinence syndrome (NAS) in an effort to improve patient outcomes. A single-center, retrospective chart review was conducted at a...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1966

    authors: DeAtley HN,Burton A,Fraley MD,Haltom J

    更新日期:2017-07-01 00:00:00

  • Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypass.

    abstract::The pharmacokinetics of methylprednisolone sodium succinate (MPHS) and methylprednisolone (MP) were determined in six patients undergoing open heart surgery with cardiopulmonary bypass. Plasma concentrations of both compounds were measured by high-performance liquid chromatography after doses of MPHS of 1.7-2.4 g. The...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Kong AN,Jungbluth GL,Pasko MT,Beam TR,Jusko WJ

    更新日期:1990-01-01 00:00:00

  • Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study.

    abstract::Infections caused by multidrug-resistant Acinetobacter baumannii have become a therapeutic challenge for clinicians worldwide. Although colistin and tigecycline have been successful in treating patients with these infections, these agents are not available on a worldwide basis. We describe four critically ill patients...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.27.11.1506

    authors: Lee NY,Wang CL,Chuang YC,Yu WL,Lee HC,Chang CM,Wang LR,Ko WC

    更新日期:2007-11-01 00:00:00

  • Serum sickness associated with 6-mercaptopurine in a patient with Crohn's disease.

    abstract::A 43-year-old man with a 19-year history of Crohn's disease experienced serum sickness with acute lobular panniculitis and vasculitis within 2 weeks of initiating 6-mercaptopurine therapy. He had no history of extraintestinal manifestations of Crohn's disease or drug allergy. Symptoms included disabling joint pain, pr...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Andersen JM,Tiede JJ

    更新日期:1997-01-01 00:00:00

  • Development of unilateral cervical and supraclavicular lymphadenopathy after human papilloma virus vaccination.

    abstract::A 26-year-old woman developed significant unilateral anterior cervical and supraclavicular lymphadenopathy 3 days after receiving her first dose (of a total of three doses) of human papilloma virus (HPV) vaccine. She had no history of lymphadenopathy after other previous immunizations, and had received no vaccines oth...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.9.1194

    authors: Studdiford J,Lamb K,Horvath K,Altshuler M,Stonehouse A

    更新日期:2008-09-01 00:00:00